PBTQ Gains, Lifted by Celgene, Genzyme Friday, October 1, 8:43 AM ET, by Market News Video Staff The PowerShares Global Biotech Portfolio (PBTQ) has a market value of only $3.7 million, but ...
ETFs Hold About $4.5 billion of Johnson & Johnson Tuesday, October 5, 7:50 AM ET, by Market News Video Staff ETFChannel.com's "ETF Components" toplist shows that aggregately ETFs hold nearly $4.5 billion of Johnson & ...
Gilead Sciences 23.68% of Biotech HOLDRS ETF Thursday, October 7, 8:24 AM ET, by Market News Video Staff Gilead Sciences (GILD) makes up 23.68% of the Biotech HOLDRS (BBH) ETF. The Biotech HOLDRS ...
ETFs Hold More Than $3.2 Billion of Pfizer Friday, October 8, 7:51 AM ET, by Market News Video Staff According to ETFChannel.com's Top ETF Stock Components list, ETFs hold over $3.2 billion of Pfizer ...
By Market News Video Staff, Monday, November 15, 12:13 PM ET
Genzyme (NASDAQ:GENZ) shares are trading higher today on media reports that it is trying to find a “white knight” to buy it for more than the $18.5 billion Sanofi-Aventis (NYSE:SNY) is offering in its hostile takeover bid.
The Mail on Sunday as well as The Wall Street Journal have reported that Genzyme has been in talks with Takeda Pharmaceutical Co.
The Journal said Takeda is unlikely to actually make a bid, and that Pfizer (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) are also considering bidding on all or part of Genzyme, although the process is in its early stages.
Genzyme shares are trading up 0.7% Monday.
At 9.93% of the Biotech HOLDRS (AMEX:BBH), Genzyme is the fourth-largest holding of the fund, which is trading up 1.1% today.
Amgen (AMGN) is the #1 holding in the fund, at 35.41% of the portfolio, followed by Gilead Sciences (GILD), at 24.8%, and Biogen Idec (BIIB), at 17.24%.
This Article's Word Cloud:AMGNAmgenAventisBIIBBiogenBiotechGENZGenzymeGileadHOLDRSIdecJohnsonJournalMailNYSEPfizerSanofiSciencesTakedaactuallyalsoalthoughconsideringfindfollowedfundhavehigherholdinghostileknightlargestmakemediaofferingportfolioprocessreportedreportssharesstagestakeovertalksthanthattodaytradingtryingunlikelywhite
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.